diabetes Archive — Page 5 of 17
-
January 31, 2022
Impact of digital health interventions
Vanderbilt researchers test and recommend statistical approaches to study the association between engagement with digital health interventions and clinical outcomes. -
January 13, 2022
Eighteen years ago Kanisha Sizemore got a new kidney and pancreas. With her job in the Transplant Pharmacy she gives patients hope and perspective.
“Being a transplant recipient is a blessing, but it is also life changing in several ways." -
January 12, 2022
Excessive screen time impacting health of children in many ways
Vanderbilt physicians are seeing an increasing trend of health conditions in children with chronic diseases like diabetes, directly or indirectly related to excessive screen time. -
November 11, 2021
New way to bEET insulin resistance
Signaling molecules called EETs could improve insulin resistance, a primary risk factor for Type 2 diabetes and cardiovascular disease, Vanderbilt researchers have discovered. -
November 11, 2021
International gathering scrutinizes immune response, beta cell biology in Type 1 diabetes
-
October 28, 2021
Pancreatic beta-cell booster
Blocking inflammatory signaling improves beta-cell characteristics in a mouse model of type 2 diabetes and may provide added benefits to GLP-1R diabetes medications. -
August 27, 2021
Study proves standardized protocol can support reliable MRI use for multisite pancreatic research
Researchers with the Vanderbilt Diabetes Research and Training Center (DRTC) at Vanderbilt University Medical Center led a multisite study which has demonstrated that, when controlled and standardized, quantitative magnetic resonance imaging (MRI) of the pancreas is highly reproducible when using different MRI hardware and software at different geographic locations.